日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Role of Digital Media in Chronic Disease Self-Management: Protocol for a Multimethod Study of the DISELMA Research Consortium

数字媒体在慢性病自我管理中的作用:DISELMA研究联盟多方法研究方案

Rossmann, Constanze; Karnowski, Veronika; Metag, Julia; Raupp, Juliana; Reifegerste, Doreen; Riesmeyer, Claudia; Sawalha, Nariman; Lux, Alexandra; Esser, Anna-Lena; Kammerer, Rebecca; Singh, Franca; Rödel, Natalie; Brill, Janine; Gerling, Elisabeth; Wiedicke, Annemarie

Predictors of Risk Perception Among General Practitioners and Paediatricians Concerning Potential Health Effects of Exposure to Electromagnetic Fields

全科医生和儿科医生对暴露于电磁场的潜在健康影响的风险认知预测因素

Lüthy, Katharina; Forster, Felix; Riesmeyer, Claudia; Ermel, Lyn; Radon, Katja; Weinmann, Tobias

Risks of electromagnetic fields from the perspective of general practitioners and pediatricians

从全科医生和儿科医生的角度来看电磁场的风险

Forster, Felix; Riesmeyer, Claudia; Ermel, Lyn; Lüthy, Katharina; Jung, Ronny; Weinmann, Tobias

Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes

过渡到活性对照试验,以评估2型糖尿病药物的心血管安全性和有效性

McGuire, Darren K; D'Alessio, David; Nicholls, Stephen J; Nissen, Steven E; Riesmeyer, Jeffrey S; Pavo, Imre; Sethuraman, Shanthi; Heilmann, Cory R; Kaiser, John J; Weerakkody, Govinda J

Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial

C反应蛋白对接受最佳治疗的高危血管疾病患者脂蛋白(a)相关心血管风险的影响:ACCELERATE试验的预设二次分析

Puri, Rishi; Nissen, Steven E; Arsenault, Benoit J; St John, Julie; Riesmeyer, Jeffrey S; Ruotolo, Giacomo; McErlean, Ellen; Menon, Venu; Cho, Leslie; Wolski, Kathy; Lincoff, A Michael; Nicholls, Stephen J

The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

替泽帕肽是一种双重葡萄糖依赖性促胰岛素肽和胰高血糖素样肽-1受体激动剂,可改善2型糖尿病患者与胰岛素抵抗和心血管风险相关的脂蛋白生物标志物。

Wilson, Jonathan M; Nikooienejad, Amir; Robins, Deborah A; Roell, William C; Riesmeyer, Jeffrey S; Haupt, Axel; Duffin, Kevin L; Taskinen, Marja-Riitta; Ruotolo, Giacomo

Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States

胰高血糖素样肽-1受体激动剂心血管结局试验结果对美国2型糖尿病总体人群的适用性

Boye, Kristina S; Riddle, Matthew C; Gerstein, Hertzel C; Mody, Reema; Garcia-Perez, Luis-Emilio; Karanikas, Chrisanthi A; Lage, Maureen J; Riesmeyer, Jeffrey S; Lakshmanan, Mark C

ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study

ADCY9 基因变异与高危血管疾病患者接受依伐曲匹治疗后的心血管结局:一项嵌套病例对照研究

Nissen, Steven E; Pillai, Sreekumar G; Nicholls, Stephen J; Wolski, Kathy; Riesmeyer, Jeffrey S; Weerakkody, Govinda J; Foster, Wendra M; McErlean, Ellen; Li, Lin; Bhatnagar, Pallav; Ruotolo, Giacomo; Lincoff, A Michael

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

一项双盲、随机、多中心 II 期研究,比较普拉格雷与安慰剂在镰状细胞病成人患者中的疗效。

Wun, Ted; Soulieres, Denis; Frelinger, Andrew L; Krishnamurti, Lakshmanan; Novelli, Enrico M; Kutlar, Abdullah; Ataga, Kenneth I; Knupp, Charles L; McMahon, Lillian E; Strouse, John J; Zhou, Chunmei; Heath, Lori E; Nwachuku, Chuke E; Jakubowski, Joseph A; Riesmeyer, Jeffrey S; Winters, Kenneth J